Mercury Bio

We want to shift the paradigm in drug delivery systems. Mercury Bio has invented a drug delivery platform designed to unleash the potential of RNA and small-molecule drugs using reliable, cell-specific deliverytargeting only the cells that need therapy and working with the body to bypass immune reactions. Not only will our technology boost patient outcomes, it will help drug developers quicken products to market by reducing many of the obstacles, delays, and risks encountered by traditional drug delivery systems, spreading the viable reach of new medications in the process. By advancing drug efficacy, lowering costs, reducing side effects, and shortening...

Drug delivery,molecular biophysics,molecular biology,microbial genetics,biochemistry,genetic & bioinformatics,computational & statistical science,and theoretical biology

Mercury bio operates in the Biotechnology research industry.

Mercury bio's revenue is 11m - 100m

Mercury bio has 11 - 50 employees.